Egnach, March 3, 2025 – Resaphene Suisse AG announces that the company has successfully completed certification for the Indian market. The certification allows the company to market and distribute its medical products in India.

This is a significant milestone for Resaphene, making it easier for us to enter the Indian market and providing our customers with the assurance that our products meet the required standards.

++ About Resaphene Suisse AG

Resaphene Suisse AG, based in Egnach, Switzerland, is a medical technology company founded in 2015 and has been marketing a tinnitus therapy device under the name tinniwell since 2016.

++ Contact for inquiries:

Resaphene Suisse AG

Ms. Anke Rauterkus (Chief Executive Officer)
Bahnhofplatz 5
9322 Egnach
Switzerland
T. +41 71 510 07 24
a.rauterkus@resaphene.ch